Published in Med Microbiol Immunol on May 01, 1999
Toxoplasma gondii: 25 years and 25 major advances for the field. Int J Parasitol (2009) 1.26
Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect Immun (2007) 1.18
Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res (2006) 1.16
Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling. J Biol Chem (2010) 0.98
Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro. Infect Immun (2004) 0.97
Toxoplasma gondii inhibits apoptosis in infected cells by caspase inactivation and NF-kappaB activation. Yonsei Med J (2006) 0.86
Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis. Infect Immun (2002) 0.83
The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis. J Ocul Biol Dis Infor (2009) 0.80
Transferrin receptor induction in Toxoplasma gondii-infected HFF is associated with increased iron-responsive protein 1 activity and is mediated by secreted factors. Parasitol Res (2004) 0.79
Toxoplasma gondii inhibits cytochrome c-induced caspase activation in its host cell by interference with holo-apoptosome assembly. Microb Cell (2015) 0.78
Toxoplasma Effectors Targeting Host Signaling and Transcription. Clin Microbiol Rev (2017) 0.75
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2010) 2.32
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol (1993) 1.50
Reevaluation of total-lymphoid irradiation and cyclosporine therapy in the Syrian hamster-to-Lewis rat cardiac xenograft model. Transplantation (1990) 1.45
Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation (1994) 1.37
Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol (2001) 1.30
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J Cell Sci (2001) 1.23
Developmental expression of a tandemly repeated, glycine- and serine-rich spore wall protein in the microsporidian pathogen Encephalitozoon cuniculi. Infect Immun (2000) 1.23
Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol (1998) 1.22
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol (1992) 1.22
Regulation of Pseudomonas aeruginosa hemF and hemN by the dual action of the redox response regulators Anr and Dnr. Mol Microbiol (1998) 1.20
Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii. J Parasitol (1994) 1.20
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol (1994) 1.19
Human tissue responses to metal stents. Gastrointest Endosc Clin N Am (1999) 1.16
Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol (1999) 1.12
Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol (2001) 1.12
Clinical aspects and pathogenesis of Candida infection. Trends Microbiol (1998) 1.10
Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 1.07
Bradyzoite-specific gene expression in Toxoplasma gondii requires minimal genomic elements. Mol Biochem Parasitol (1997) 1.07
Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res (1997) 1.06
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology (1997) 1.06
Active secretion of S100B from astrocytes during metabolic stress. Neuroscience (2006) 1.05
Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. Curr Top Microbiol Immunol (2005) 1.05
Subclass-specific serological reactivity and IgG4-specific antigen recognition in human echinococcosis. Trop Med Int Health (1997) 1.05
Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material. Biomaterials (1994) 1.03
Genetic manipulation of virulence of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 1.03
Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization. Mol Genet Genomics (2001) 1.02
Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med Microbiol Immunol (2003) 1.00
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients. Clin Biochem (2000) 1.00
A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation (1994) 1.00
Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients. Lancet (1996) 0.99
Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest Endosc (1996) 0.97
Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem Parasitol (1998) 0.97
Toxoplasma gondii virulence markers identified by random amplified polymorphic DNA polymerase chain reaction. Parasitol Res (1997) 0.96
[Taenia crassiceps infection in AIDS]. Dtsch Med Wochenschr (1992) 0.96
Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol (1995) 0.94
Stage differentiation of the protozoan parasite Toxoplasma gondii. Immunobiology (1999) 0.94
Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface. J Biomed Mater Res (1995) 0.93
Evaluation of calcium phosphates and experimental calcium phosphate bone cements using osteogenic cultures. J Biomed Mater Res (2000) 0.92
The ability of selected oral microorganisms to emit red fluorescence. Caries Res (2006) 0.92
Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients? J Parasitol (2000) 0.91
Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups. J Clin Microbiol (1997) 0.91
Coexistence of heterogeneous populations of Toxoplasma gondii parasites within parasitophorous vacuoles of murine macrophages as revealed by a bradyzoite-specific monoclonal antibody. Parasitol Res (1993) 0.90
Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. J Clin Microbiol (1997) 0.90
Massive osteolysis (Gorham-Stout syndrome) in the maxillofacial region: an unusual manifestation. Int J Oral Maxillofac Surg (1996) 0.89
Risk factors associated with early-onset sepsis in premature infants. Eur J Obstet Gynecol Reprod Biol (1999) 0.89
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology (1999) 0.89
Bradyzoite-specific genes. Curr Top Microbiol Immunol (1996) 0.89
In vitro investigation of titanium and hydroxyapatite dental implant surfaces using a rat bone marrow stromal cell culture system. Biomaterials (2002) 0.88
Reactivation of chronic toxoplasmosis: is there a link to strain-specific differences in the parasite? Behring Inst Mitt (1997) 0.88
Different manifestations of Toxoplasma gondii infection in F344 and LEW rats. Med Microbiol Immunol (1999) 0.87
[Campylobacteriosis of man : livestock as reservoir for Campylobacter species]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.87
High incidence of toxoplasmosis during pregnancy in Nigeria. Scand J Infect Dis (1996) 0.87
Effects of cadmium on the immune system of mice. Experientia (1979) 0.86
Histologic evaluation of a natural permanent percutaneous structure and clinical percutaneous devices. Biomaterials (1999) 0.86
Toxoplasma gondii strain-specific transcript levels of SAG1 and their association with virulence. Parasitol Res (1996) 0.86
Regulation of developmental differentiation in the protozoan parasite Toxoplasma gondii. J Eukaryot Microbiol (1996) 0.86
Suppression of delayed type hypersensitivity of mice by lead. Experientia (1977) 0.86
Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema. Brain Res (1983) 0.85
The ultrastructure of the interface between a glass ceramic and bone. J Biomed Mater Res (1981) 0.85
Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis. J Clin Microbiol (2000) 0.84
Induction of interleukin-8 in human neutrophils after MHC class II cross-linking with superantigens. J Leukoc Biol (2001) 0.84
Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria. Eur J Biochem (1998) 0.83
Generation of rabbit anti-lymphocyte monoclonal antibodies. Transplant Proc (1993) 0.83
High-throughput scanning of the rat genome using interspersed repetitive sequence-PCR markers. Genomics (2000) 0.83
Diagnosis of human allograft rejection by flow cytometry using two-color fluorescence and monoclonal antibodies. Transplant Proc (1987) 0.82
Toxoplasmosis: from clinics to basic science. Parasitol Today (1998) 0.82
A method for immunohistochemical detection of osteogenic markers in undecalcified bone sections. Biotech Histochem (2006) 0.82
Tissue engineering of biphasic joint cartilage transplants. Biomaterials (1999) 0.81
Compound heterozygous hereditary coproporphyria with fluorescing teeth. Ann Clin Biochem (1999) 0.81
Veto cells in transplantation tolerance. Clin Transplant (1994) 0.81
The interface of various glasses and glass ceramics with a bony implantation bed. J Biomed Mater Res (1985) 0.81
Incorporation and degradation of hydroxyapatite implants of different surface roughness and surface structure in bone. Scanning Microsc (1990) 0.80
Toxoplasma gondii: a paraformaldehyde-insensitive diaphorase activity acts as a specific histochemical marker for the single mitochondrion. Exp Parasitol (1998) 0.80
Modified pendulum appliance including distal screw and uprighting activation for non-compliance therapy of Class-II malocclusion in children and adolescents. J Orofac Orthop (2000) 0.80
The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany. J Inherit Metab Dis (2004) 0.80
Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading. Clin Biochem (1999) 0.79
Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria. Hum Genet (1998) 0.79
Bradyzoite-specific expression of a P-type ATPase in Toxoplasma gondii. Mol Biochem Parasitol (2001) 0.79
Differentiation between mouse-virulent and -avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen. J Clin Microbiol (1993) 0.79
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells. Br J Cancer (1997) 0.79
Fixed lingual arch appliance for compliance-free unilateral molar distalization in the mandible. Three case studies. J Orofac Orthop (2000) 0.79
Perspectives for the tissue engineering of cartilage from a biological and biomaterial point of view. J Appl Biomater Biomech (2010) 0.78
Alcohol and porphyrin metabolism. Alcohol Alcohol (2000) 0.78
Ultrastructural and histochemical investigations of spindle-shaped corpuscles in phagocytic cells of lymph nodes. Beitr Pathol (1977) 0.78
Comparison of different protocols for DNA preparation and PCR for the detection of fungal pathogens in vitro. Mycoses (2006) 0.78
Cyst formation by Toxoplasma gondii in vivo and in brain-cell culture: a comparative morphology and immunocytochemistry study. Parasitol Res (1997) 0.78
[Glass ceramics as a bioactive implantation material]. Dtsch Zahnarztl Z (1976) 0.78
Primary mineralization and extracellular matrix vesicles in rat bone after administration of glass-ceramic implants. Arch Orthop Trauma Surg (1981) 0.78
SEM study of surface alterations of bioactive glasses and glass--ceramics in a bony implantation bed. Clin Mater (1990) 0.78
Short-term human chondrocyte culturing on oriented collagen coated gelatine scaffolds for cartilage replacement. Biomed Mater Eng (2005) 0.78